The Food and Drug Administration recently approved two novel thrombopoiesis-stimulating agents, Romiplostim (AMG-531, Nplate) and Eltrombopag (Promacta), for the treatment of adults with immune ...
OBJECTIVE: To determine the most effective, evidence-based approach to the use of platelet transfusions in patients with cancer. OUTCOMES: Outcomes of interest included prevention of morbidity and ...
(HealthDay News) — Autologous platelet transfusion 24 or 48 hours after ticagrelor-mediated platelet inhibition has minimal effect, while a small reversing effect is seen for transfusion after ...
When someone is diagnosed with cancer, people often look for ways to help. One way to help is to donate blood or platelets. Patients diagnosed with cancer may need a blood transfusion for many ...
The UAB Hospital’s Transfusion Services, or Blood Bank, is the largest of the clinical laboratories with 40+ employees working under Lakecia Watkins, laboratory supervisor. They staff the main ...
Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up. Seventy-eight patients undergoing induction therapy for acute leukemia were randomized to receive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback